About this trial
The goal of this clinical trial will be to evaluate the effect applying an experimental gel based on cannabidiol oil (CBD) on tooth sensitivity induced by tooth bleaching with 35% hydrogen peroxide (HP). Volunteers will be selected and allocated to the following groups: GP - placebo gel, GCBD - experimental cannabidiol gel and GKF - Potassium Nitrate and Sodium Fluoride Gel. In each group, the corresponding desensitizing gel will be applied to on the teeth for 10 minutes. All groups will then undergo in-office whitening treatment with 35% hydrogen peroxide. Patients will be instructed to record tooth sensitivity on a daily basis during the 21 days of follow-up. Pain intensity will be measured using a visual analog scale (VAS), while the risk of developing sensitivity will be recorded after each session of the whitening procedure, with two response option.
Eligibility criteria
Qualifiers
Participants must have at least 28 teeth in the cavity
Good oral and general health
Disqualifiers
active caries or periodontal disease
visible cracks in front teeth upper or lower
with evident malocclusion
restorations and prosthetics in teeth anterior teeth
Trial design
Treatments tested in this trial
- Potassium nitrate and sodium fluoride
- Cannabidiol (CBD) Gel
- Natrosol 4% Gel